![](/img/cover-not-exists.png)
Improved Lipid Lowering Activity of Bezafibrate Following Continuous Gastrointestinal Administration: Pharmacodynamic Rationale for Sustained Release Preparation of the Drug
Amnon Hoffman, Yossef Lomnicky, Myron H. Luria, Dalia Gilhar, Michael FriedmanVolume:
16
Pages:
5
DOI:
10.1023/a:1018900219616
Date:
July, 1999
File:
PDF, 1.01 MB
1999